Interaction between growth hormone and insulin in the regulation of lipoprotein metabolism in the rat

American Journal of Physiology - Endocrinology and Metabolism

Volumn 283, Issue 5 46-5, 2002, Pages

  Frick, Fredrik ^a   Lindén, Daniel ^a   Améen, Caroline ^a   Mode, Agneta ^b   Oscarsson, Jan ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Adipose tissue; ApoB mRNA editing; Apolipoprotein B; Apolipoprotein E; Fatty acid synthase; Liver; Stearoyl CoA desaturase; Sterol regulatory element binding protein 1; Triglyceride secretion

Indexed keywords

ACYL COENZYME A DESATURASE; APOLIPOPROTEIN B; APOLIPOPROTEIN E; FAS LIGAND; FATTY ACID SYNTHASE; GROWTH HORMONE; HIGH DENSITY LIPOPROTEIN; INSULIN; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; MESSENGER RNA; STEAROYL COENZYME A DESATURASE 1; STEROL REGULATORY ELEMENT BINDING PROTEIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; HORMONE ACTION; HYPOPHYSECTOMY; LIPID METABOLISM; LIPOGENESIS; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; LIVER LEVEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RAT STRAIN; SECRETION;

EID: 0036838945     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00260.2002     Document Type: Article

References (50)

1. Angelin B and Rudling M. Growth hormone and hepatic lipoprotein metabolism. Curr Opin Lipidol 5: 160-165, 1994.
2. Chirieac DV, Chirieac LR, Corsetti JP, Cianci J, Sparks CE, and Sparks JD. Glucose-stimulated insulin secretion suppresses hepatic triglyceride-rich lipoprotein and apoB production. Am J Physiol Endocrinol Metab 279: E1003-E1011, 2000.
3. Christ ER, Cummings MH, Albany E, Umpleby AM, Lumb PJ, Wierzbicki AS, Naoumova RP, Boroujerdi MA, Sonksen PH, and Russell-Jones DL. Effects of growth hormone (GH) replacement therapy on very low density lipoprotein apolipoprotein B100 kinetics in patients with adult GH deficiency: A stable isotope study. J Clin Endocrinol Metab 84: 307-316, 1999.
4. Cummings MH, Watts GF, Umpleby AM, Hennessy TR, Naoumova R, Slavin BM, Thompson GR, and Sonksen PH. Increased hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in NIDDM. Diabetologia 38: 959-967, 1995.
5. Donkin SS, McNall AD, Swencki BS, Peters JL, and Etherton TD. The growth hormone-dependent decrease in hepatic fatty acid synthase mRNA is the result of a decrease in gene transcription. J Mol Endocrinol 16: 151-158, 1996.
6. Edén S. Age- and sex-related differences in episodic growth hormone secretion in the rat. Endocrinology 105: 555-560, 1979.
7. Elam MB, Simkevich CP, Solomon SS, Wilcox HG, and Heimberg M. Stimulation of in vitro triglyceride synthesis in the rat hepatocyte by growth hormone treatment in vivo. Endocrinology 122: 1397-1402, 1988.
8. Elam MB, Wilcox HG, Cagen LM, Deng X, Raghow R, Kumar P, Heimberg M, and Russell JC. Increased hepatic VLDL secretion, lipogenesis, and SREBP-1 expression in the corpulent JCR:LA-cp rat. J Lipid Res 42: 2039-2048, 2001.
9. Elam MB, von Wronski MA, Cagen L, Thorngate F, Kumar P, Heimberg M, and Wilcox HG. Apolipoprotein B mRNA editing and apolipoprotein gene expression in the liver of hyperinsulinemic fatty Zucker rats: Relationship to very low density lipoprotein composition. Lipids 34: 809-816, 1999.
10. Elam MB, Wilcox HG, Solomon SS, and Heimberg M. In vivo growth hormone treatment stimulates secretion of very low density lipoprotein by the isolated perfused rat liver. Endocrinology 131: 2717-2722, 1992.
11. Etherton TD. The biology of somatotropin in adipose tissue growth and nutrient partitioning. J Nutr 130: 2623-2625, 2000.
12. Flores-Morales A, Stfihlberg N, Tollet-Egnell P, Lundeberg J, Malek RL, Quackenbush J, Lee NH, and Norstedt G. Microarray analysis of the in vivo effects of hypophysectomy and growth hormone treatment on gene expression in the rat. Endocrinology 142: 3163-3176, 2001.
13. Foretz M, Guichard C, Ferre P, and Foufelle F. Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes. Proc Natl Acad Sci USA 96: 12737-12742, 1999.
14. Frick F, Bohlooly YM, Lindén D, Olsson B, Törnell J, Edén S, and Oscarsson J. Long-term growth hormone excess induces marked alterations in lipoprotein metabolism in mice. Am J Physiol Endocrinol Metab 281: E1230-E1239, 2001.
15. Frick F, Oscarsson J, Vikman-Adolfsson K, Ottosson M, Yoshida N, and Edén S. Different effects of IGF-I on insulin-stimulated glucose uptake in adipose tissue and skeletal muscle. Am J Physiol Endocrinol Metab 278: E729-E737, 2000.
16. Frohman LA and Bernardis LL. Growth hormone secretion in the rat: Metabolic clearance and secretion rates. Endocrinology 86: 305-312, 1970.
17. Gause I, Isaksson O, Lindahl A, and Edén S. Effect of insulin treatment of hypophysectomized rats on adipose tissue responsiveness to insulin and growth hormone. Endocrinology 116: 945-951, 1985.
18. Gibbons GF. Assembly and secretion of hepatic very-low-density lipoprotein. Biochem J 268: 1-13, 1990.
19. Hansen LH, Madsen B, Teisner B, Nielsen JH, and Billestrup N. Characterization of the inhibitory effect of growth hormone on primary preadipocyte differentiation. Mol Endocrinol 12: 1140-1149, 1998.
20. Horton JD and Shimomura I. Sterol regulatory element-binding proteins: Activators of cholesterol and fatty acid biosynthesis. Curr Opin Lipidol 10: 143-150, 1999.
21. Jansson JO, Ekberg S, Isaksson O, Mode A, and Gustafsson JA. Imprinting of growth hormone secretion, body growth, and hepatic steroid metabolism by neonatal testosterone. Endocrinology 117: 1881-1889, 1985.
22. Koopmans SJ, Kushwaha RS, and DeFronzo RA. Chronic physiologic hyperinsulinemia impairs suppression of plasma free fatty acids and increases de novo lipogenesis but does not cause dyslipidemia in conscious normal rats. Metabolism 48: 330-337, 1999.
23. Lewis GF. Fatty acid regulation of very low density lipoprotein production. Curr Opin Lipidol 8: 146-153, 1997.
24. Li X, Catalina F, Grundy SM, and Patel S. Method to measure apolipoprotein B-48 and B-100 secretion rates in an individual mouse: Evidence for a very rapid turnover of VLDL and preferential removal of B-48-relative to B-100-containing lipoproteins. J Lipid Res 37: 210-220, 1996.
25. Lindén D, Sjöberg A, Asp L, Carlsson L, and Oscarsson J. Direct effects of growth hormone on production and secretion of apolipoprotein B from rat hepatocytes. Am J Physiol Endocrinol Metab 279: E1335-E1346, 2000.
26. Malaisse WJ, Malaisse-Lagae F, King S, and Wright PH, Effect of growth hormone on insulin secretion. Ant J Physiol 215: 423-428, 1968.
27. Nielsen JH. Effects of growth hormone, prolactin, and placental lactogen on insulin content and release, and deoxyribonucleic acid synthesis in cultured pancreatic islets. Endocrinology 110: 600-606, 1982.
28. Ntambi JM. Regulation of stearoyl-CoA desaturase by polyunsaturated fatty acids and cholesterol. JLipid Res 40:1549-1558, 1999.
29. Oscarsson J, Olofsson SO, Bondjers G, and Edén S. Differential effects of continuous versus intermittent administration of growth hormone to hypophysectomized female rats on serum lipoproteins and their apoproteins. Endocrinology 125: 1638-1649, 1989.
30. Oscarsson J, Ottosson M, and Edén S. Effects of growth hormone on lipoprotein lipase and hepatic lipase. J Endocrinol Invest 22: 2-9, 1999.
31. Oscarsson J, Ottosson M, Vikman-Adolfsson K, Frick F, Enerbäck S, Lithell H, and Edén S. GH but not IGF-I or insulin increases lipoprotein lipase activity in muscle tissues of hypophysectomised rats. J Endocrinol 160: 247-255, 1999.
32. Pierluissi J, Pierluissi R, and Ashcroft SJ. Effects of growth hormone on insulin release in the rat. Diabetologia 19: 391-396, 1980.
33. Pittner RA, Bracken P, Fears R, and Brindley DN. Insulin antagonises the growth hormone-mediated increase in the activity of phosphatidate phosphohydrolase in isolated rat hepatocytes. FEBS Lett 202: 133-136, 1986.
34. Rizza RA, Mandarino LJ, Genest J, Baker BA, and Gerich JE. Production of insulin resistance by hyperinsulinaemia in man. Diabetologia 28: 70-75, 1985.
35. Rizza RA, Mandarino LJ, and Gerich JE. Effects of growth hormone on insulin action in man. Mechanisms of insulin resistance, impaired suppression of glucose production, and impaired stimulation of glucose utilization. Diabetes 31: 663-669, 1982.
36. Roberts TJ, Azain MJ, Hausman GJ, and Martin RJ. Interaction of insulin and somatotropin on body weight gain, feed intake, and body composition in rats. Am J Physiol Endocrinol Metab 267: E293-E299, 1994.
37. Salomon F, Cuneo RC, Hesp R, and Sonksen PH. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med 321: 1797-1803, 1989.
38. Semenkovich CF. Regulation of fatty acid synthase (FAS). Prog Lipid Res 36: 43-53, 1997.
39. Shimano H. Sterol regulatory element-binding proteins (SREBPs): Transcriptional regulators of lipid synthetic genes. Prog Lipid Res 40: 439-452, 2001.
40. Shimomura I, Bashmakov Y, Ikemoto S, Horton JD, Brown MS, and Goldstein JL. Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetes. Proc Natl Acad Sci USA 96: 13656-13661, 1999.
41. Shimomura I, Matsuda M, Hammer RE, Bashmakov Y, Brown MS, and Goldstein JL. Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice. Mol Cell 6: 77-86, 2000.
42. Sjöberg A, Oscarsson J, Borén J, Edén S, and Olofsson SO. Mode of growth hormone administration influences triacylglycerol synthesis and assembly of apolipoprotein B-containing lipoproteins in cultured rat hepatocytes. J Lipid Res 37: 275-289, 1996.
43. Sjöberg A, Oscarsson J, Boström K, Innerarity TL, Edén S, and Olofsson SO. Effects of growth hormone on apolipoprotein-B (apoB) messenger ribonucleic acid editing, and apoB 48 and apoB 100 synthesis and secretion in the rat liver. Endocrinology 130: 3356-3364, 1992.
44. Sjöberg A, Oscarsson J, Olofsson SO, and Edén S. Insulin-like growth factor-I and growth hormone have different effects on serum lipoproteins and secretion of lipoproteins from cultured rat hepatocytes. Endocrinology 135: 1415-1421, 1994.
45. Sonksen PH, Greenwood FC, Ellis JP, Lowy C, Rutherford A, and Nabarro JD. Changes of carbohydrate tolerance in acromegaly with progress of the disease and in response to treatment. J Clin Endocrinol Metab 27: 1418-1430, 1967.
46. Sparks JD and Sparks CE. Insulin regulation of triacylglycerol-rich lipoprotein synthesis and secretion. Biochim Biophys Acta 1215: 9-32, 1994.
47. Thorngate FE, Raghow R, Wilcox HG, Werner CS, Heimberg M, and Elam MB. Insulin promotes the biosynthesis and secretion of apolipoprotein B-48 by altering apolipoprotein B mRNA editing. Proc Natl Acad Sci USA 91: 5392-5396, 1994.
48. Tollet-Egnell P, Flores-Morales A, Ståhlberg N, Malek RL, Lee N, and Norstedt G. Gene expression profile of the aging process in rat liver: Normalizing effects of growth hormone replacement. Mol Endocrinol 15: 308-318, 2001.
49. Zammit VA, Waterman IJ, Topping D, and McKay G. Insulin stimulation of hepatic triacylglycerol secretion and the etiology of insulin resistance. J Nutr 131: 2074-2077, 2001.
50. Zechner R. The tissue-specific expression of lipoprotein lipase: implications for energy and lipoprotein metabolism. Curr Opin Lipidol 8: 77-88, 1997.